webinar register page

Webinar banner
Why Cessation is a Vital Part of Tobacco Policy


Apr 22, 2021 10:35 AM

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Linda Bailey, JD, MHS
President and CEO @North American Quitline Consortium (NAQC)
Ms. Bailey is the founder of NAQC and has served as its President & CEO since 2004. In this position she provides leadership and strategic vision for the organization. Linda has had a notable career in public health as an attorney, educator and epidemiologist. Prior positions have included director, Center for Tobacco Cessation (American Cancer Society); associate director, Center for Disease Control and Prevention’s Office on Smoking and Health in Washington, D.C. (US DHHS); senior advisor on health promotion and disease prevention, Office of the Assistant Secretary of Health (US DHHS); study director, Institute of Medicine; and epidemiologist, Houston Health Department. She has served on faculty at Johns Hopkins School of Public Health and the University of Maryland School of Law, and holds a bachelor’s degree from Tufts University, a master’s in health sciences from Johns Hopkins School of Hygiene and Public Health and a law degree from the University of Maryland School of Law.
Robert Totanes, MD, MHEM
Technical Officer, Noncommunicable Diseases (NCDs) and Injuries, Social Determinants of Health @World Health Organization
Robert is currently part of the Ambassador team for NCDs and Injuries at WHO, working on the global investment case for NCDs. His previous role includes providing technical assistance to Member States on tobacco taxation, supporting global and regional data analysis, and research related to the economics of tobacco control. He joined the organization in 2017 to focus his work on fiscal policies and other interventions that have significant health impact. Prior to his time at WHO, Robert was based in the Philippines under a USAID grantee organization, working on a wide portfolio which included policy analysis on health financing, reproductive health, and Universal Health Coverage, among others. He is a Doctor of Medicine (MD) and holds a joint Master's degree in Health Economics and International Health and Social Management.
Martin Raw, PhD
Visiting Professor @New York University School of Global Public Health & Director @International Centre for Tobacco Cessation (ICTC)
In 1982 Martin Raw co-authored the first clinical trial demonstrating that nicotine gum works. In 1998 he lead-authored the first English smoking cessation guidelines, which resulted in cessation treatment being offered through the National Health Service (NHS). In 2009/10 he led the writing of the WHO Framework Convention on Tobacco Control Article 14 guidelines, on tobacco cessation, which were adopted in 2010, and are currently official policy for 181 countries. Currently, the ICTC helps countries improve their tobacco cessation treatment. He was awarded the American Cancer Society 2012 Luther Terry Award for Outstanding Individual Leadership, and in 2017 the Society for Research in Nicotine and Tobacco 2017 John Slade Award, which honours SRNT members who have made outstanding contributions to public health and tobacco control through science-based public policy and public advocacy.